Items where Author is "Stewart, R."
Number of items: 3.
LEYLAND, Rebecca, WATKINS, A., MULGREW, K.A., HOLOWECKYJ, N., BAMBER, L., TIGUE, N.J., OFFER, E., ANDREWS, J., YAN, L., MULLINS, S., OBERST, M.D., ULRICHSEN, J.C., LEINSTER, D.A., MCGLINCHEY, K., YOUNG, L., MORROW, M., HAMMOND, S.A., MALLINDER, P., HERATH, A., CHING LEOW, C., WILKINSON, R.W. and STEWART, R.
(2017).
A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy that Is Further Enhanced in Combination with an OX40 Agonist.
Clinical Cancer Research, 23 (13), 3416-3427.
[Article]
WILLIAMS, G.S., MISTRY, B., GUILLARD, S., ULRICHSEN, J.C., SANDERCOCK, A.M., WANG, J., GONZÁLEZ-MUÑOZ, A., PARMENTIER, J., BLACK, C., SODEN, J., FREETH, J., JOVANOVIC, J., LEYLAND, Rebecca, AL-LAMKI, R.S., LEISHMAN, A.J., RUST, S.J., STEWART, R., JERMUTUS, L., BRADLEY, J.R., BEDIAN, V., VALGE-ARCHER, V., MINTER, R. and WILKINSON, R.W.
(2016).
Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy.
Oncotarget, 7 (42), 68278-68291.
[Article]
MAIER, Patrick, STEWART, R. and TRINDER, P.W.
(2014).
Reliable scalable symbolic computation: The design of SymGridPar2.
Computer Languages, Systems & Structures, 40 (1), 19-35.
[Article]